Stockreport

Calithera Biosciences Highlights Breadth of Innovative Pipeline at R&D Day

Calithera Biosciences, Inc.  (CALA) 
Last calithera biosciences, inc. earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: calithera.com
PDF -Updated response rate of 50% in advanced renal carcinoma treated with CB-839 + cabozantinib-CB-839 clinical trial collaboration with Pfizer -Presentation of INCB001158 [Read more]